ARCHIVES

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

This article is from The Cancer Letter archive.

Vol. 03 No. 47 | November 25, 1977

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Two activists Are Appointed To Complete NCAB

May 31, 1991

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Applications Due Sept. 1 For Cancer Prevention Fellows

May 10, 1991

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979